Chemical & Engineering News: Latest News

BioNTech to buy fellow German mRNA firm CureVac

The all-stock transaction will be worth around $1.25 billion

Jun 12, 2025 - 18:35
 0
BioNTech to buy fellow German mRNA firm CureVac
The all-stock transaction will be worth around $1.25 billion
Read More

Tags:

Previous Article

BMS-owned RayzeBio licenses Philochem asset for $350 million up front

Next Article

Happy birthday quantum mechanics! I got a ticket to the ultimate physics party

Related Posts

What to know when you’re let go

What to know when you’re let go

May 12, 2025  0

Grove Biopharma launches to develop therapeutic protein-like-polymers

Grove Biopharma launches to develop therapeutic protein...

May 12, 2025  0

US EPA eyes higher user fees for chemical reviews amid agency budget cuts

US EPA eyes higher user fees for chemical reviews amid ...

Jun 3, 2025  0